Not just another ChatGPT: Why life sciences needs domain-specific AI
This blog explains what GPTs are, why using ChatGPT for life sciences isn’t ideal, and…
Certara2025 年 10 月 24 日
Mathematical modeling and the monkey king: Use of modeling for more efficient NHP study design
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic…
Certara2024 年 10 月 30 日
4 ways that mechanistic modeling accelerates bispecific (and multispecific) antibody drug development
With nine FDA-approved drugs today, 100+ in clinical development and several hundred in the preclinical…
Certara2024 年 9 月 12 日
Quantitative systems pharmacology (QSP) modeling for immunotherapy-induced cytokine release syndrome
Quantitative systems pharmacology (QSP) modeling for immunotherapy-induced cytokine release syndrome
Cytokine Release Syndrome Cytokine release syndrome (CRS) is an inflammatory immune reaction that clinically manifests…
Certara2024 年 8 月 20 日
Drug discovery platform unlocks scientific data access
The D360 desktop application supports drug discovery workflows, data access, and early development research data…
Certara2024 年 7 月 12 日
How drug discovery tools aid pharma decision-making
Learn how drug discovery tools can help pharmaceutical industry professionals make more informed decisions based…
Certara2024 年 3 月 22 日
Understanding the role of your discovery asset’s target product profile
If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…
Certara2024 年 1 月 19 日
Leveraging AI to accelerate drug discovery: Vyasa joins Certara
Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…
Certara2023 年 3 月 10 日
